This added mechanism may support faster fat loss, better metabolic function, and potentially improved results for people with obesity or insulin resistance
Tirzepatide (Zepbound) is two levers: eat less and process food better
Comprehensive alpha, beta and delta cell transcriptomes reveal that ghrelin selectively activates delta cells and promotes somatostatin release from pancreatic islets
We believe in your potential to achieve greatness and we'll do everything we can to help you get there
Our team of experts will be glad to help you on your journey to a healthier life
Phase 2 trial (NEJM, 2023) The landmark Phase 2 trial, published in the New England Journal of Medicine, randomized 338 adults with obesity to receive weekly subcutaneous retatrutide at doses of 1 mg, 4 mg, 8 mg, or 12 mg, or placebo, for 48 weeks